Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

Navidea's sentinel lymph node detection agent Lymphoseek gets marketing approval in Europe Navidea Biopharmaceuticals has received marketing authorization from the European Commission for Lymphoseek (technetium Tc 99m tilmanocept) injection 250mg kit. Drug Research > Drug Delivery > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Lilly's Trulicity solution for injection gets European approval to treat type 2 diabetes
By PBR Staff Writer
Eli Lilly and Company has received marketing authorization from the European Commission for Trulicity (dulaglutide) solution for injection to improve glycaemic control in adults with type 2 diabetes.
News
Amgen and AstraZeneca report positive Phase III trial results of plaque psoriasis drug brodalumab
By PBR Staff Writer
Amgen and AstraZeneca have reported positive results from its multi-arm Phase III AMAGINE-2 trial of brodalumab to treat patients with moderate-to-severe plaque psoriasis.
News

Drug Discovery & Development

Oxford and Menarini begins first-in-human trial of leukemia drug OBT357
By PBR Staff Writer
Oxford BioTherapeutics and Menarini Group have started the first-in-human clinical trial of OBT357 (MEN1112), a new improved antibody to treat acute myeloid leukemia (AML).
News
AstraZeneca's Duaklir Genuair gets marketing approval in Europe for COPD
By PBR Staff Writer
AstraZeneca has received marketing authorisation from the European Commission (EC) for its Duaklir Genuair (aclidinium bromide/formoterol fumarate 340/12mcg) to be used as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
News